(Q44262891)

1 December 2017

title

Cefotaxime treatment of gram-negative enteric meningitis in infants and children (English)

1 reference

1 December 2017

main subject

Gram-negative bacteria

0 references

1 reference

1 reference

R F Jacobs

1

1 reference

1 December 2017

publication date

1 January 1988

1 reference

1 December 2017

1 reference

1 December 2017

volume

35 Suppl 2

1 reference

1 December 2017

page(s)

185-189

1 reference

Cefotaxime therapy of neonatal gram-negative bacillary meningitis.

1 December 2017

cites work

1 reference

12 December 2020

Changes in the pattern of neonatal septicemia and meningitis

1 reference

12 December 2020

Intraventricular use of aminoglycosides in the treatment of gram-negative bacillary meningitis: conflicting views

1 reference

12 December 2020

Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms

1 reference

12 December 2020

A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group

1 reference

12 December 2020

Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation.

1 reference

12 December 2020

Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis

1 reference

12 December 2020

Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins

1 reference

12 December 2020

A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in neonates

1 reference

12 December 2020

Cefotaxime Levels in Ventricular Cerebrospinal Fluid, Determined by Bioassay and by High-Performance Liquid Chromatography

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in newborn infants

1 reference

12 December 2020

Cefotaxime diffusion into cerebrospinal fluid of children with meningitis

1 reference

12 December 2020

Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children

1 reference

12 December 2020

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

1 reference

12 December 2020

Report of the Task Force on Diagnosis and Management of Meningitis

1 reference

12 December 2020

Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study.

1 reference

12 December 2020

Cefotaxime therapy. Evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity

1 reference

12 December 2020

The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis

1 reference

12 December 2020

Experience with the use of cefotaxime in the treatment of bacterial meningitis.

1 reference

12 December 2020

Identifiers

1 reference